These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 15901795
1. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels. Chen HS, Lipton SA. J Pharmacol Exp Ther; 2005 Sep; 314(3):961-71. PubMed ID: 15901795 [Abstract] [Full Text] [Related]
2. The chemical biology of clinically tolerated NMDA receptor antagonists. Chen HS, Lipton SA. J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772 [Abstract] [Full Text] [Related]
3. Mechanism of action of memantine. Johnson JW, Kotermanski SE. Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266 [Abstract] [Full Text] [Related]
4. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors. Gilling KE, Jatzke C, Hechenberger M, Parsons CG. Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579 [Abstract] [Full Text] [Related]
5. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL. Grauert M, Rho JM, Subramaniam S, Rogawski MA. J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625 [Abstract] [Full Text] [Related]
13. [Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine]. Kato T. Clin Calcium; 2004 Aug; 14(8):76-80. PubMed ID: 15577101 [Abstract] [Full Text] [Related]
14. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine. Gilling KE, Jatzke C, Parsons CG. Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186 [Abstract] [Full Text] [Related]
15. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Wafford KA, Kathoria M, Bain CJ, Marshall G, Le Bourdellès B, Kemp JA, Whiting PJ. Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047 [Abstract] [Full Text] [Related]